Research on new and better ways to treat cancer. Covers radiotherapy, targeted microdroplets, nerve-injury protection, drug combinations, and tumor models.
Renowned scientists and clinicians will discuss recent advances in breast cancer science and treatment, including new developments in imaging techniques, hormone replacement therapy, and alternative therapies. The symposium will feature prominent speakers from top medical institutions.
A six-month study found that isoflavone-rich soy protein isolate attenuated bone loss in the lumbar spine of perimenopausal women. The treatment group showed a significant reduction in bone mineral density and content compared to the control group. This suggests that soy may be a useful adjunct therapy for preventing osteoporosis in wo...
Researchers found that women are less likely to receive early treatment following a heart attack, including aspirin and thrombolytic therapy. Despite this, there is no apparent effect on 30-day mortality rates when accounting for severity of illness and other factors.
Targeted Genetics Corporation has shown promise in its AAV gene therapy program for rheumatoid arthritis (RA), reducing ankle and hind paw swelling in preclinical studies. The treatment uses a recombinant TNFR:Fc fusion protein, which antagonizes the function of TNF-a, a key component of the inflammatory response.
A new software program developed by Emory researchers uses data from 840 previous patients to predict outcomes in new patients. The genetic adaptive model has an accuracy rate of 76 percent and can help determine a patient's chances of cancer recurrence after treatment, guiding doctors towards the best treatment option.
The Montreal Prostate Cancer Model estimates high disease-specific survival rates following prostatectomy, with comparable results to SEER data. The model also forecasts significant economic burdens of prostate cancer in Canada, totaling $9.76 billion over a lifetime.
The Charter of Paris Against Cancer aims to improve cancer care, research, and treatment worldwide. The initiative brings together global partners to fight cancer, with a focus on patient involvement and advocacy.
The ACP-ASIM End-of-Life Care Consensus Panel provides guidance on identifying and managing depression in dying patients, which can improve their quality of life. The panel's recommendations are based on state-of-the-art psychosocial interventions and/or drug treatments.
A study by UCSF researcher Shelley Adler found that only a third of women with breast cancer disclose using alternative treatments to their medical doctors. The main reasons for remaining silent were attitudes toward physicians and the perception that disclosure was not relevant to the doctor-patient relationship. Women tend to discuss...
A study of over 6,000 patients found that one in every 100 people misdiagnosed due to a single pathologist's report. This can lead to incorrect treatment, surgery, or chemotherapy, causing psychological trauma and financial burden.
A recent study published in Annals of Internal Medicine found that illness severity, rather than age, is a key predictor of death among seriously ill patients. The research analyzed data from over 9,000 hospitalized patients and found that those with the sickest conditions were at highest risk of dying within six months.
A study of 292 breast cancer survivors found that involvement in decision-making about follow-up tests improved physical and emotional health, but did not affect post-cancer survival rates. Leading cancer experts recommend mammography and clinical breast exams instead.
A recent study published in the Journal of Periodontology found that smokers have lower success rates with periodontal treatment, requiring further treatment nearly 43% of the time. Quitting smoking can improve oral health and reduce risks associated with heart disease and cancer.
A Harvard Medical School study reveals that physician guidelines for estrogen replacement therapy fail to address women's concerns and needs. Researchers found that patients value healthcare provider opinions, media influences, and friend opinions when making decisions about hormone replacement therapy.
The American Society of Gene Therapy is hosting its 2nd Annual Meeting, featuring key researchers and NIH director Harold Varmus. The event showcases the latest advancements in gene therapies for various genetic disorders, including AIDS, cardiovascular disease, cancer, cystic fibrosis, and neuromuscular diseases.
A USCF study reveals that an herbal therapy, PC-SPES, significantly reduces prostate-specific antigen (PSA) levels by more than 50% in men with advanced prostate cancer. The compound, containing eight Chinese herbs including saw palmetto, showed promising results in both hormone-naïve and hormone-resistant patients.
The study found that the costs of treating patients in clinical trials were modestly higher than for those who opted for standard treatment, with an average total cost of $46,424. The authors recommend payment for patients' treatment in National Cancer Institute-approved clinical trials to improve access and patient outcomes.
Researchers have identified specific immune responses in patients treated with high doses of interferon alfa 2b to prevent melanoma recurrence. High-dose IFNa2b modulated the expression of MHC Class II antigens and increased natural killer cell activity, which may lead to better patient selection and therapy options.
A new study by UCSF researchers found that applying well-established business techniques to medical consultations improves breast cancer patients' treatment decisions. Patients reported higher levels of satisfaction, decision quality, and agreement with physicians about their treatment choices.
A new ventilator treatment has been shown to significantly reduce mortality among victims of Acute Respiratory Distress Syndrome (ARDS) by 25%. The treatment involves providing smaller breaths of oxygen-rich air, which may protect the lung from injury. This life-saving breakthrough could save thousands of lives annually.
Researchers at Columbia University Irving Medical Center identified the P-TEN gene as a new breast cancer susceptibility gene. The discovery could lead to better tests for early detection and more effective treatments for women with Cowden's syndrome, an autosomal dominant disorder that increases breast cancer risk by 50-75%.
A study published in Cancer found that women with breast cancer who received care at a multi-disciplinary clinic had definitive treatment within 29.6 days, compared to 42.2 days for those seeing specialists sequentially. Patients are also more satisfied with their care, wanting quick resolution and comprehensive support.
A new laser technique called photodynamic therapy appears to prevent further vision loss in people with the wet form of age-related macular degeneration. The treatment uses a red laser light to activate a toxic form of oxygen that stops abnormal blood vessel growth, potentially confining scar tissue and preventing vision loss.
Researchers have identified an inactive gene that contributes to cancer development when it fails to work in harmony with the tumor-suppressing p53 gene. The findings suggest that the bax gene can act as a tumor suppresser, and its dysfunction may lead to increased cancer cell death and tumor growth.
Researchers at Cornell University have successfully determined the structure of a newly identified key protein, expanding our understanding of cellular function and potential therapeutic targets. The discovery opens doors to further investigation of this protein's role in various diseases.